aurobindo pharma, business, cin treatment, companies, evive biotech

Aurobindo Pharma

Aurobindo Pharma on Wednesday said its unit has entered into a licensing pact with Evive Biotech to commercialise Ryzneuta in the US market.

The product, a novel dimeric G-CSF long-acting fusion protein without pegylation, is currently under late-stage review by the US Food and Drug Administration for chemotherapy-induced neutropenia (CIN).

In addition to the US health regulator, Evive’s Marketing Authorization Application (MAA), and New Drug Application (NDA) for Ryzneuta are currently under review by European and Chinese regulators.

Neutropenia is a common side-effect of chemotherapy and is a condition characterised by low levels of neutrophils, a type of white blood cell that fights infection.

The licensing pact has been inked between Evive and Acrotech Biopharma (Acrotech), a New Jersey-based and wholly-owned subsidiary of Aurobindo Pharma USA Inc, Aurobindo Pharma said in a statement.

As part of the agreement, Evive will be responsible for the ongoing development, manufacturing, registration, and supply of Ryzneuta, while Acrotech will use its sales and commercialisation capabilities to market and distribute the product in the US, it added.

“Ryzneuta provides Acrotech the opportunity to expand its offerings to oncology patients and is aligned with our vision of commercialising scientifically advanced products. Additionally, expanding into CIN creates future growth opportunities for us,” Acrotech Biopharma President Ashish Anvekar said.

Evive CEO Simon Li said despite the current options, CIN remains a significant clinical condition for most cancer patients, creating the need for more potent and convenient treatment.

“Acrotech has proven and strong capacity to commercialise proprietary medications, we look forward to partnering with them for bringing this novel medicine to more cancer patients with CIN in the US,” he added.

Evive Biotech, a subsidiary of Yifan Pharmaceutical, is a global biopharmaceutical company devoted to developing a portfolio of novel biological therapies for patients worldwide.

TECH NEWS RELATED

Macrotech Developers' promoters plan to raise Rs 3,500 crore via sale of shares to institutional investors

Macrotech Developers Realty firm Macrotech Developers’ promoters plan to raise about Rs 3,500 crore by selling shares to institutional investors, according to sources. Mumbai-based Macrotech Developers sells its properties under the Lodha brand. In a regulatory filing late on Wednesday, Macrotech Developers informed that the company has launched Qualified ...

View more: Macrotech Developers' promoters plan to raise Rs 3,500 crore via sale of shares to institutional investors

Irdai proposes 3 years insurance cover for cars, 5 years for two-wheelers

Regulator Irdai proposed to introduce an insurance cover of three years for cars and five years for two-wheelers with an aim to allow wider choice to customers. The Insurance Regulatory and Development Authority of India (Irdai) has floated a draft on ‘Long-Term Motor Products covering both Motor Third Party ...

View more: Irdai proposes 3 years insurance cover for cars, 5 years for two-wheelers

LineVision, GE Grid Solutions Partner up To Fortify the Electrical Grid

Tech companies Linevision and GE Grid Solutions team up to unlock additional capacity for transmission lines. Until now, nearly a terawatt of zero-carbon generating capacity is yet to be hooked on electrical grids, which is enough to decarbonize 80% of US electricity by the decade’s end. In order to provide ...

View more: LineVision, GE Grid Solutions Partner up To Fortify the Electrical Grid

Triveni Engineering promoter likely to sell 7.03% stake via block deal tomorrow

(Representative image) Sugar firm Triveni Engineering & Industries Ltd’s promoter Dhruv Sawhney is likely to sell a 7.03 percent stake, approximately 1.7 crore shares, via block deals on December 8, CNBC Awaaz reported on December 7 citing sources. The promoter is aiming to sell shares worth Rs 500 crore at Rs ...

View more: Triveni Engineering promoter likely to sell 7.03% stake via block deal tomorrow

Indian Startup Byju's To Restructure $1.2 Billion Loan Amidst Steep Losses

One of the most valuable Indian startups, Byju’s, plans to restructure its $1.2 billion loan while dealing with cost reduction targets. According to Bloomberg, the online education firm Byju’s is attempting to renegotiate its $1.2 billion debt as it struggles with doubling losses and cost-cutting goals. The company has reportedly hired ...

View more: Indian Startup Byju's To Restructure $1.2 Billion Loan Amidst Steep Losses

GMR Airports, NIIF announce financial partnership; NIIF to invest in 3 airport projects

GMR Airports Ltd and National Investment and Infrastructure Fund (NIIF) on Wednesday announced a financial partnership under which NIIF will invest in three airport projects. The investment by NIIF will include the Rs 631 crore in the greenfield international airport at Mopa (Goa), which is set for inauguration on ...

View more: GMR Airports, NIIF announce financial partnership; NIIF to invest in 3 airport projects

Coal import by power sector rises to 39 MT in April-October FY23

Import of coal by the power sector has increased in ongoing financial year and the sector imported 38.84 million tonne (MT) of the dry fuel in April-October period, Parliament was informed on Wednesday. “…import of coal by the power sector increased during current financial year of 2022-23. As against ...

View more: Coal import by power sector rises to 39 MT in April-October FY23

Audi to hike vehicle prices by up to 1.7% from January

Luxury carmaker Audi on Wednesday said it will increase prices of its model range by up to 1.7 per cent, with effect from January 1, 2023. The company said it is hiking the prices due to an increase in input and operational costs. “The primary objective of the company’s ...

View more: Audi to hike vehicle prices by up to 1.7% from January

Mahua Acharya resigns as MD, CEO of state-owned CESL

Promoter abrdn Investment plans to sell entire 10.2% stake in HDFC AMC

Vedanta to raise up to Rs 500 crore via debentures

FTX’s Sam Bankman-Fried Was a ‘Master Manipulator,’ Says Binance CEO CZ

Elon Musk’s brain implant company is facing federal probe on animal testing

Jet Airways case: NCLAT dismisses Jalan-Kalrock plea on unpaid provident fund, gratuity dues

Samsung to increase investment in Vietnam to $20 billion this year

Jet Airways revival hits new snag as banks push back on funding

Flying colours: Future flights to have more orderly disembarking system

Samsung might soon get replaced as India’s top smartphone exporter

Ban on BS-III petrol, BS-IV diesel vehicles: Transporters' body to hold protests against Delhi, Punjab govts

Ambassador Taranjit Singh Sandhu meets Microsoft CEO Satya Nadella

OTHER TECH NEWS

Top Car News Car News